Lithium, a Common Drug for Bipolar Disorder Treatment, Regulates Amyloid-β Precursor Protein Processing
- 12 May 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 43 (22), 6899-6908
- https://doi.org/10.1021/bi035627j
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase ComplexNeuron, 2003
- Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 DegradationPublished by Elsevier BV ,2002
- Coexpression of GSK-3β Corrects Phenotypic Aberrations of Dorsal Root Ganglion Cells, Cultured from Adult Transgenic Mice Overexpressing Human Protein tauNeurobiology of Disease, 2002
- Alzheimer's Disease: Genes, Proteins, and TherapyPhysiological Reviews, 2001
- Functional gamma‐secretase inhibitors reduce beta‐amyloid peptide levels in brainJournal of Neurochemistry, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- The Transmembrane Aspartates in Presenilin 1 and 2 Are Obligatory for γ-Secretase Activity and Amyloid β-Protein GenerationPublished by Elsevier BV ,2000
- Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3β transgenesNeuroReport, 1997
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinNature, 1995
- Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's DiseaseJournal of Neurochemistry, 1986